Multifocal avascular necrosis after liver transplantation: An unusual presentation of the antiphospholipid syndrome

Lupus

Volumn 15, Issue 5, 2006, Pages 304-307

  Mundo, J ^a   Peris, Pilar ^a,b   Monegal, A ^a   Navasa, M ^a   Cervera, R ^a   Guanabens N ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Aseptic necrosis; Avascular necrosis; Ischemic necrosis

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; CORTICOSTEROID; CYCLOSPORIN A; LUPUS ANTICOAGULANT;

ADULT; ANAMNESIS; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AVASCULAR NECROSIS; CASE REPORT; CLINICAL FEATURE; FOOT PAIN; HIP DISEASE; HUMAN; HUMERUS; KNEE PAIN; LABORATORY TEST; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; TARSAL BONE; TREATMENT WITHDRAWAL;

ACENOCOUMAROL; ADRENAL CORTEX HORMONES; ADULT; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; FEMUR HEAD NECROSIS; FOLLOW-UP STUDIES; HIP; HUMANS; HUMERUS; KNEE; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; OSTEONECROSIS; PERIOSTITIS; TARSAL BONES; TIBIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 33744828260     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203306lu2301cr     Document Type: Article

References (25)

1. Mankin HJ. Non traumatic osteonecrosis of bone (osteonecrosis). N Eng J Med 1992; 326: 1473-1478.
2. Lieberman JR, Scaduto AA, Wellmeyer E. Symptomatic osteonecrosis of the hip after orthotopic liver transplantation. J Arthroplasty 2000; 15; 767-771.
3. Tektonidou MG, Moutsopoulos HM. Inmunologic factors in the pathogenesis of the osteonecrosis. Orthop Clin North Am 2004; 35: 259-263.
4. Migliaresi S, Picillo U, Ambrosone L et al. Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and cardiolipin antibodies. Lupus 1994; 3: 37-41.
5. Nawasawa K, Ishii Y, Mayumi T et al. Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostathic abnormalities. Ann Rheum Dis 1989; 48: 672-676.
6. Alarcon-Segovia D, Deleze M, Orja CV et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989; 68: 353-365.
7. Mok CC, Lau CS, Womg RWS. Risk factors for vascular necrosis in systemic lupus erythematosus. Br J Rheumatol 1998; 37: 895-900.
8. Asherson RA, Liote F, Page B et al. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 1993; 20: 284-288.
9. Bronster DJ, Gousse R, Fassas A, Rand JH. Anticardiolipin antibody-associated stroke after liver transplantation. Transplantation 1997; 63: 908-909.
10. Collier JD, Sale J, Friend PJ, Jamieson NV, Calne RY, Alexander GJ. Graft loss and the antiphospholipid syndrome following liver transplantation. J Hepatol 1998; 29: 999-1003.
11. Van Thiel DH, George M, Brems J et al. Antiphospholipid antibodies before and after liver transplantation. Am J Gastroenterol 2003; 98: 460-465.
12. Laroche M, Ludot I, Thiechart M, Viguier G, Dromer C, Mazieres B. Histological appearance of the intra-osseous vessels of the femoral head in aseptic osteonecrosis of the hip, with or without antiphospholipid antibodies. Clin Rheumatol 1997; 16: 367-371.
13. Mok MY, Farewell VT, Isenberg DA. Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies? Ann Rheum Dis 2000; 59: 462-467.
14. Lee JS, Koo KH, Ha YC et al. Role of thrombotic and fibrinolytic disorders in osteonecrosis of the femoral head. Clin Orthop 2003; 417: 270-276.
15. Cervera R, Piette JC, Font J et al. Antiphospholipid syndrome. Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 2002; 46: 1019-1027.
16. Tektonidou MG, Malagari K, Vlachoyiannopoulos PG, Kelekis DA, Moutsopoulos HM. Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging. Arthritis Rheum 2003; 48: 732-736.
17. Jones LC, Mont MA, Le TB et al. Procoagulants and osteonecrosis. J Rheumatol 2003; 30: 783-791.
18. Yasutomi M, Egawa H, Kobayashi Y, Oike F, Tanaka K. Living donor liver transplantation for Budd-Chiari syndrome with inferior vena cava obstruction and associated antiphospholipid antibody syndrome. J Pediatr Surg 2001; 36: 659-662.
19. Vivarelli M, La Barba G, Legnani C et al. Repeat graft loss caused by recurrent hepatic artery thrombosis after liver transplantation. Liver Transpl 2003; 9: 629-631.
20. Stone JH, Amend WJ, Criswell LA. Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus. Am J Kidney Dis 1999; 34: 1040-1047.
21. McIntyre JA, Wagenknecht DR. Antiphospholipid antibodies and renal transplantation: a risk assessment. Lupus 2003; 12: 555-559.
22. Forman J, Lin J, Pascual M, Denton MD, Tolkoff-Rubin N. Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation. Am J Transplant 2004; 4: 1786-1791.
23. Andrassy J, Zeier M, Andrassy K. Do we need screening for thrombophilia prior to kidney transplantation? Nephrol Dial Transplant 2004; 19 (Suppl 4): iv64-iv68.
24. Egan RM, Jun RK. Catastrophic antiphospholipid antibody syndrome presenting with multiple thromboses and sites of avascular necrosis. J Rheumatol 1994; 21: 2376-2379.
25. Yoo W-H. Multiple rib infarcts: a rare form of osteonecrosis in antiphospholipid syndrome. Ann Rheum Dis 2004; 63: 457-458.